Who is nobody? Investors apparently don’t care about being an integral part of the next SOC? Your shortness is showing. Please go and put on some pants.
Agreed. Without large non dilutive upfront cash, this is going nowhere, even after UK approval. It will stay under $1 and likely fall back to where to are now after a brief spike as the market digests disappointing earnings from the UK and no upfront financial support from big pharma over the next quarter or two.